update on treatment of seizures epilepsy l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
“Update on Treatment of Seizures & Epilepsy” PowerPoint Presentation
Download Presentation
“Update on Treatment of Seizures & Epilepsy”

Loading in 2 Seconds...

play fullscreen
1 / 38

“Update on Treatment of Seizures & Epilepsy” - PowerPoint PPT Presentation


  • 363 Views
  • Uploaded on

“Update on Treatment of Seizures & Epilepsy”. Bassel F. Shneker, MD Comprehensive Epilepsy Program The Ohio State University October 24, 2009. Outline. Definition of Seizures and Epilepsy Treatment with AEDs Newly Approved AEDs New information about AEDs Generic AEDs

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about '“Update on Treatment of Seizures & Epilepsy”' - Lucy


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
update on treatment of seizures epilepsy

“Update on Treatment of Seizures & Epilepsy”

Bassel F. Shneker, MD

Comprehensive Epilepsy Program

The Ohio State University

October 24, 2009

outline
Outline
  • Definition of Seizures and Epilepsy
  • Treatment with AEDs
  • Newly Approved AEDs
  • New information about AEDs
    • Generic AEDs
    • Suicidality and AEDs
    • Pregnancy and AEDs
definition of seizures
Definition of Seizures
  • Time-limited paroxysmal events that result from abnormal, involuntary, rhythmic neuronal discharges in the brain
  • Seizures are usually unpredictable
  • Seizures usually brief ( < 5 minutes) and stop spontaneously
  • Convulsion, ictus, event, spell, attack and fit are used to refer to seizures
etiology of seizures
Etiology of Seizures
  • Seizures are either provoked or unprovoked
  • Provoked Seizures: Triggered by certain provoking factors in otherwise healthy brain
        • Metabolic abnormalities (hypoglycemia and hyperglycemia, hyponatremia, hypocalcemia)
        • Alcohol withdrawal
        • Acute neurological insult (infection, stroke, trauma)
        • Illicit drug intoxication and withdrawal
        • Prescribed medications that lower seizure threshold (theophylline, TCA)
        • High fever in children
  • Unprovoked Seizures: Occur in the setting of persistent brain pathology
definition of epilepsy
Definition of Epilepsy
  • A disease characterized by spontaneous recurrence of unprovoked seizures (at least 2)
  • Seizures are symptoms, while epilepsy is a disease, so those terms should not be used interchangeably
  • Epilepsy = “seizure disorder”
  • Epilepsy is a syndromic disease
  • Each epilepsy syndrome is determined based on;

Type of seizures, age at seizure onset, family history, physical exam, EEG findings, and neuroimaging

etiology of epilepsy
Etiology of Epilepsy
  • Any process that alters the structure (macroscopic or microscopic) or the function of the brain neurons can cause epilepsy
  • Processes that lead to structural alteration include;
      • Congenital malformation
      • Degenerative disease
      • Infectious disease
      • Trauma
      • Tumors
      • Vascular process
  • In majority of patients, the etiology is proposed but not found
treatment of seizures
Treatment of Seizures
  • Provoked Seizures
    • Treatment directed to the provoking factor
  • Unprovoked Seizures
    • First Seizure
      • Usually no treatment
      • Treatment can be initiated if risk of recurrence is high or if a second seizure could be devastating
    • Second Seizure
      • Diagnosis of epilepsy is established and risk of a third Seizure is high
      • Most physician treat at this stage
      • In children, some may wait for a third seizure
treatment of established epilepsy
Treatment of Established Epilepsy
  • First Line
    • Approved Anti-Epileptic Drugs (AEDs)
  • Second Line (intractable epilepsy)
    • Epilepsy Surgery
    • Vagus Nerve Stimulation Therapy
  • Exeprimental Treatment
    • AEDs
    • Devices
      • Deep Brain Stimulator (DBS)
      • Responsive Neuro Stimulator (RNS)
what is new in aeds world
What is New in AEDs World?
  • 3 AEDs are approved in 2009
    • Rufinamide (Banzel®)
    • Lacosamide (Vimpat®)
    • Vigabitrin (Sabril®)
  • Discussion about generic vs. brand AEDs
  • Suicidality and AEDs
  • Pregnancy and AEDs
aed generic trade abbreviations
Phenobarbital/Primidone

PB / PRM

Phenytoin (Dilantin)

PHT

Carbamazepine (Tegretol)

CBZ

Valproic Acid (Depakote)

VPA

Felbamate (Felbatol)

FBM

Gabapentin (Neurontin)

GBP

Lamotrigine (Lamictal)

LTG

Topiramate (Topamax)

TPM

Tiagabine (Gabitril)

TGB

Oxcarbazepine (Trileptal)

OCBZ (OXC)

Levetiracetam (Keppra)

LEV (LVT)

Zonisamide (Zonegran)

ZNS

Pregabalin (Lyrica)

PGB

Rufinamide (Banzel)

RUF

Lacosamide (Vimpat)

LCM

Vigabatrin (Sabril)

VGB

AED Generic (Trade) Abbreviations
aed therapy
AED Therapy

TGB

TPM

FOS

PGB

LTG

ZNS

LEV

VGB

GBP

VPA

OCBZ

RUF

PB

PHT

CBZ

FBM

LCM

generic vs brand aeds
Generic vs. Brand AEDs
  • Advantage
    • Lower cost
    • Increase access to treatment
  • Disadvantage
    • Lower level seizures
    • Higher level CNS toxicity
generic drug fda requirements
Generic Drug- FDA Requirements
  • Generic drug must:
    • Contain same active ingredients
    • Identical in strength, dosage form, and route of administration
    • Same use indications
    • Bioequivalent
    • Same batch requirements for identity, strength, purity, and quality
    • Manufactured under the same strict standards of FDA's good manufacturing practice regulations required for innovator products
bioequivalence requirement
Bioequivalence Requirement
  • “A generic product has to be bioequivalent to the brand (reference) product by demonstrating the same in vivo performance”
    • Mainly absorption
  • Two drugs are bioequivalent if the ratio of means of the primary PK responses such as AUC and Cmax between the two formulations of the same drug or the two drug products is within (80%, 125%) with 90% assurance.
questions about generic aeds
Questions about Generic AEDs
  • Switch between generics
  • Controlled vs. uncontrolled epilepsy patients
  • Data about negative impact of generics
fda alert results 1
FDA Alert – Results (1)
  • Data from 199 placebo-controlled trials
    • 43,892 total patients
      • 27,863 drug-treated patients
      • 16,029 placebo-treated patients
  • Indications:
    • Epilepsy: 62 trials (31%)
    • Psychiatric Indications: 56 trials (28%)
    • Other Indications: 81 trials (41%)
  • Analyzed AEDs (11): CBZ, FBM, GBP, LTG, LEV, OXC, PGB, TGB, TPM, VPA, ZNS
fda alert results 3
FDA Alert – Results (3)
  • Drug-treated subjects had approximately twice the risk of suicidal behavior or ideation (0.43%) compared with placebo-treated subjects (0.22%)
  • Risk was higher in epilepsy group compared to other groups
  • Risk difference 2.1 per 1000 (95% CI: 0.7, 4.2)
  • Increased risk observed throughout time periods for which data was obtained
  • No clear pattern of risk across age groups
  • Results generally consistent across all drugs
fda alert so what
FDA Alert, So What?
  • “The mean scores for the FDA alert clarity, appropriateness, and impact on clinical practice (on a scale from 1 to 10) were low, at 5.3, 4.1, and 3.6. Almost 46% did not feel the alert is going to change their practice “

Shneker, Neurology 2009

  • Concerns about
    • What to do
    • Patient safety from stopping AEDs
aeds pregnancy
AEDs & Pregnancy
  • Discussion about effect of AEDs on Fetus
    • Malformations
    • Cognitive side effects
  • Latest Information
    • AED Pregnancy Registry
    • Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study
background on aed pregnancy registry
Background on AED Pregnancy Registry
  • For pregnant women taking any AED
      • For epilepsy or non-epilepsy purpose
    • Patients call 1-888-AED-AED4
    • www.aedpregnancyregistry.org
  • Three telephone calls
    • Initial (10 min), 7 months (5 min), Post-partum (5 min)
aed pregnancy registry enrollment data
AED Pregnancy Registry Enrollment Data

www.AEDpregnancyregistry.org Winter 2009 Newsletter

what do we know now
What do we know now?
  • Risk of Major Malformations
    • Polytherapy = ↑ risk
    • Specific AEDs
      • General population = 1.6%
      • Phenobarbital = 6.5%
      • Valproic Acid = 10.7%
  • August 2006 Neurology (Meador, et al.)
    • NEAD Study with 333 pregnancies
      • Serious adverse outcomes (major malfs, fetal death)
        • CBZ (8.2%), LTG (1.0%), PHT (10.7%), VPA (20.3%)
lamotrigine recent findings
Lamotrigine Recent Findings
  • AED Pregnancy Registry Data
    • 564 infants LTG monotherapy 1st trimester
    • Between 1997 & March 2006
      • Major malformations 2.7%
        • vs. 1.6% unexposed
      • 5 infants cleft lip/palate = 1:113
        • vs. 1:6,160 unexposed
        • Relative risk LTG = 32.8
      • Other AED registries = 1:405
aeds neurodevelopment
AEDs & Neurodevelopment
  • “Although we’ve had a great deal of information in the past 2 years on anatomical teratogenicity from AED in utero exposure, we have had much less with regard to cognitive outcomes. Animal studies of AEDs clearly show behavioral teratogenesis at dosages less than those required to produce anatomical teratogenicity.”

Meador KJ. 2006

aeds neurodevelopment34
Adab 2001 (UK)

Additional Educational Needs

VPA = 30%, CBZ = 3.2%

Adab 2004 (UK)

Verbal IQ lower in VPA-exposed than other AEDs

Failey 2002 (FIN)

Mean Verbal IQ Scores

VPA 82, CBZ 96, Controls 95

Eriksson 2005 (FIN)

Low intelligence

VPA 19% vs. CBZ 0%

NEAD Study

Prospective evaluation of long

term cognitive and behavioral

development

AEDs & Neurodevelopment
aeds neurodevelopment35
AEDs & Neurodevelopment
  • NEAD Study
    • Pregnant women on monotherapy
      • CBZ, LTG, PHT or VPA
    • Long-term goal = examine cognition at age 6
      • Planned interim analyses at 3 yrs
    • Mental Scale of the Bayley Scales of Infant Development
        • CBZ (n=73), LTG (n=84), PHT (n=48), VPA (n=53)
        • Children’s Mental Development Index (MDI)
          • Controlled (Mom’s IQ, AED levels, Sz type, etc)

Meador et al. N Engl J Med 2009;360:1597-1605.

aeds neurodevelopment36
AEDs & Neurodevelopment
  • VPA-exposed kids significantly lower IQ scores
    • Dose-dependent
    • Conclusion
      • “. . .recommendation that valproate not be used as a 1st choice drug in women of childbearing potential.”
aeds pregnancy take home messages
AEDs & Pregnancy – Take Home Messages
  • No Safe AEDs
  • Optimization of pre-pregnancy treatment
    • Monotherapy
    • Lowest dose
  • Advise women to plan pregnancy
  • Avoid VPA
  • All childbearing age women should be on folic acid
acknowledgment
Acknowledgment
  • James McAuley, PhD
    • Co-investigator, slides
  • John Elliott, MPH
  • Janet Renner
  • Stephanie Renner